partner and we confirmed the interaction by immunoprecipitation.
We have developed anti-Evc2 antibodies and show that Evc2 and Evc co-localise at the basal body and also in primary cilia. In transfected cells, basal body and cilia localisation are only observed when Evc and Evc2 constructs are co-transfected but do not occur when either construct is transfected individually indicating that this localisation is co-dependent. Although Evc localises to cilia it is not essential for ciliogenesis; chondrocyte cilia from mice lacking Evc appear structurally normal on transmission electron microscopy. Finally, we have demonstrated that Evc and Evc2 are cilia transmembrane proteins by immunostaining in permeabilised and non-permeabilised cells, the C-terminus for both being intracellular and Evc2, but not Evc, having an extracellular portion. This was also seen for FLNa and nesprin-2 indicating that mutation of ABPs could lead, or contribute, to a ciliopathy phenotype.
In MKS patient fibroblasts, nuclear membrane architecture was distorted and cell-migration reduced; both indicative of disruption of the actin cytoskeleton. In addition, RhoA-GTPase activity was increased. Small GTPases are key regulators of actin assembly and remodelling pathways and the appearance of actin stress fibres was concurrent with this increased activity. Both 
